Media coverage
85
Media coverage
Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet USA Life Sciences Database Country/Territory Switzerland Date 16/01/25 URL www.usalifesciences.com/us/portal/news_details.php?news_id=43879851k$SnderFYAEjCE&page_id=?next=1 Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet MedIndia Country/Territory India Date 16/01/25 URL https://www.medindia.net/health-press-release/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory--701338-1.htm Persons Marla Dubinsky Title USFDA approves Eli Lilly Omvoh for Crohn's disease Media name/outlet Medical Dialogues Country/Territory India Date 16/01/25 URL https://medicaldialogues.in/news/industry/pharma/usfda-approves-eli-lilly-omvoh-for-crohns-disease-141628 Persons Marla Dubinsky Title FDA approves Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet BioSpace Country/Territory United States Date 16/01/25 URL https://www.biospace.com/press-releases/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease Persons Marla Dubinsky Title FDA approves Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet PipelineReview Country/Territory Spain Date 16/01/25 URL https://pipelinereview.com/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease/ Persons Marla Dubinsky Title FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 15/01/25 Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet PR Newswire Country/Territory United States Date 15/01/25 URL https://www.prnewswire.com/news-releases/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease-302352349.html Persons Marla Dubinsky Title PR NewswireFDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Finanzen.net Country/Territory Germany Date 15/01/25 URL https://www.finanzen.net/nachricht/aktien/fda-approves-lilly-s-omvoh-mirikizumab-mrkz-for-crohn-s-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease-14155224 Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet ADVFN UK Country/Territory United Kingdom Date 15/01/25 URL https://uk.advfn.com/stock-market/NYSE/LLY/share-news/FDA-approves-Lillys-Omvoh-mirikizumab-mrkz-for-Cr/95256055 Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease | LLY Stock News Media name/outlet StockTitan.net Country/Territory United States Date 15/01/25 URL https://www.stocktitan.net/news/LLY/fda-approves-lilly-s-omvoh-mirikizumab-mrkz-for-crohn-s-disease-9tho5wvgs4vc.html Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Le Lezard.com Country/Territory Canada Date 15/01/25 URL https://www.lelezard.com/en/news-21669310.html Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Yahoo! Finance Country/Territory United States Date 15/01/25 URL https://finance.yahoo.com/news/fda-approves-lillys-omvoh-mirikizumab-210600325.html Persons Marla Dubinsky Title FDA approves Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet APNews.com Country/Territory United States Date 15/01/25 URL https://apnews.com/press-release/pr-newswire/medication-clinical-trials-u-s-food-and-drug-administration-d88f4b88b9caced08a3364496458ca21 Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet MarketScreener.com Country/Territory United States Date 15/01/25 URL https://www.marketscreener.com/quote/stock/ELI-LILLY-AND-COMPANY-13401/news/FDA-approves-Lilly-s-Omvoh-mirikizumab-mrkz-for-Crohn-s-disease-expanding-its-use-to-the-second-48776396/ Persons Marla Dubinsky Title FDA approves Lilly's Omvoh(TM) (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Stockwatch Country/Territory Canada Date 15/01/25 URL www.stockwatch.com/News/Item/U-DE95329-U!LLY-20250115/U/LLY Persons Marla Dubinsky Title FDA approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Chase Country/Territory United States Date 15/01/25 URL https://idc.chase.com/newspublic/story?article=3565ce915d77f193&controller=newspublic&action=search&module=default Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Greenville Business Magazine Country/Territory United States Date 15/01/25 URL https://pr.greenvillebusinessmag.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Canadian Insider Country/Territory Canada Date 15/01/25 URL https://www.canadianinsider.com/fda-approves-lilly-s-omvoh-mirikizumab-mrkz-for-crohn-s-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet News-Journal Country/Territory United States Date 15/01/25 URL https://www.news-journal.com/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second/article_6556ccb2-d254-5c12-85e8-109cf0ddb3b4.html Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Auburn Citizen Country/Territory United States Date 15/01/25 URL https://auburnpub.com/online_features/press_releases/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second/article_923cebd0-0245-52a0-961e-05851355ede9.html Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Berkshire Eagle Country/Territory United States Date 15/01/25 URL https://www.berkshireeagle.com/online_features/press_releases/fda-approves-lillys-omvoh-mirikizumab-mrkz-for-crohns-disease-expanding-its-use-to-the-second/article_5b1cb4cf-b486-50fa-a6a6-7180436d3732.html Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Brunswick Times-Gazette Country/Territory United States Date 15/01/25 URL https://www.brunswicktimes-gazette.com/online_features/press_releases/article_8a5cee53-1f89-594a-8dde-fdbf5f9231db.html Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Picayune Item Country/Territory United States Date 15/01/25 URL https://smb.picayuneitem.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Salisbury Post Country/Territory United States Date 15/01/25 URL https://smb.salisburypost.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Kenbridge Victoria Dispatch Country/Territory United States Date 15/01/25 URL https://smb.kenbridgevictoriadispatch.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Stanly News & Press Country/Territory United States Date 15/01/25 URL https://smb.thesnaponline.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Magnolia State Live Country/Territory United States Date 15/01/25 URL https://smb.magnoliastatelive.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Coastland Times Country/Territory United States Date 15/01/25 URL https://smb.thecoastlandtimes.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Orange Leader Country/Territory United States Date 15/01/25 URL https://smb.orangeleader.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Roanoke Chowan News Herald Country/Territory United States Date 15/01/25 URL https://smb.roanoke-chowannewsherald.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Elizabethton.com Country/Territory United States Date 15/01/25 URL https://smb.elizabethton.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Davie County Enterprise Record Country/Territory United States Date 15/01/25 URL https://smb.ourdavie.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Austin Daily Herald Country/Territory United States Date 15/01/25 URL https://smb.austindailyherald.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Leader Publications Country/Territory United States Date 15/01/25 URL https://smb.leaderpub.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Ironton Tribune Country/Territory United States Date 15/01/25 URL https://smb.irontontribune.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Cordele Dispatch Country/Territory Georgia Date 15/01/25 URL https://smb.cordeledispatch.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Troy Messenger Country/Territory United States Date 15/01/25 URL https://smb.troymessenger.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Prentiss Headlight Country/Territory United States Date 15/01/25 URL https://smb.prentissheadlight.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Riverton Journal Country/Territory United States Date 15/01/25 URL https://pr.rivertonjournal.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Shelby County Reporter Country/Territory United States Date 15/01/25 URL https://smb.shelbycountyreporter.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet NorfolkWrentham - Local Town Pages Country/Territory United States Date 15/01/25 URL https://pr.norfolkwrenthamnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Jessamine Journal Country/Territory United States Date 15/01/25 URL https://smb.jessaminejournal.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Claiborne Progress Country/Territory United States Date 15/01/25 URL https://smb.claiborneprogress.net/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Suffolk News Herald Country/Territory United States Date 15/01/25 URL https://smb.suffolknewsherald.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Panolian Country/Territory United States Date 15/01/25 URL https://smb.panolian.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Charlotte Gazette Country/Territory United States Date 15/01/25 URL https://smb.thecharlottegazette.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Holliston - Local Town Pages Country/Territory United States Date 15/01/25 URL https://pr.hollistontownnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Winchester Sun Country/Territory United States Date 15/01/25 URL https://smb.winchestersun.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Smithfield Times Country/Territory United States Date 15/01/25 URL https://smb.smithfieldtimes.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Port Arthur News Country/Territory United States Date 15/01/25 URL https://smb.panews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet TheTidewaterNews.com Country/Territory United States Date 15/01/25 URL https://smb.thetidewaternews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Greenville Advocate Country/Territory United States Date 15/01/25 URL https://smb.greenvilleadvocate.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Washington Daily News Country/Territory United States Date 15/01/25 URL https://smb.thewashingtondailynews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Demopolis Times Country/Territory United States Date 15/01/25 URL https://smb.demopolistimes.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet The Advocate-Messenger Country/Territory United States Date 15/01/25 URL https://smb.amnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet L' Observateur Country/Territory United States Date 15/01/25 URL https://smb.lobservateur.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet BluegrassLive.com Country/Territory United States Date 15/01/25 URL https://smb.bluegrasslive.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Times of San Diego Country/Territory United States Date 15/01/25 URL https://pr.timesofsandiego.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet The Brewton Standard Country/Territory United States Date 15/01/25 URL https://smb.brewtonstandard.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Selma Times-Journal Country/Territory United States Date 15/01/25 URL https://smb.selmatimesjournal.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Clemmons Courier Country/Territory United States Date 15/01/25 URL https://smb.clemmonscourier.net/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Daily Leader.com Country/Territory United States Date 15/01/25 URL https://smb.dailyleader.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Southwest Daily News Country/Territory United States Date 15/01/25 URL https://smb.southwestdailynews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Alexander City Outlook Country/Territory United States Date 15/01/25 URL https://smb.alexcityoutlook.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Interior Journal Country/Territory United States Date 15/01/25 URL https://smb.theinteriorjournal.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Alabama Now Country/Territory United States Date 15/01/25 URL https://smb.alabamanow.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Frankfort State Journal Country/Territory United States Date 15/01/25 URL https://smb.state-journal.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Gates County Index Country/Territory United States Date 15/01/25 URL https://smb.gatescountyindex.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Leesville Leader Country/Territory United States Date 15/01/25 URL https://smb.theleesvilleleader.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet The Oxford Eagle Country/Territory United States Date 15/01/25 URL https://smb.oxfordeagle.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Atmore Advance Country/Territory United States Date 15/01/25 URL https://smb.atmoreadvance.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Andalusia Star Country/Territory United States Date 15/01/25 URL https://smb.andalusiastarnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Post-Searchlight Country/Territory Georgia Date 15/01/25 URL https://smb.thepostsearchlight.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Franklin- Local Town Pages Country/Territory United States Date 15/01/25 URL https://pr.franklintownnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet ValleyTimes-News.com Country/Territory United States Date 15/01/25 URL https://smb.valleytimes-news.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Clanton Advisor Country/Territory United States Date 15/01/25 URL https://smb.clantonadvertiser.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet MillisMedway - Local Town Pages Country/Territory United States Date 15/01/25 URL https://pr.millismedwaynews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Lowndes Signal Country/Territory United States Date 15/01/25 URL https://smb.lowndessignal.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Chester County Press (Oxford, Pennsylvania) Country/Territory United States Date 15/01/25 URL https://pr.chestercounty.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Vicksburg Post Country/Territory United States Date 15/01/25 URL https://smb.vicksburgpost.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Hopedale - Local Town Pages Country/Territory United States Date 15/01/25 URL https://pr.hopedaletownnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Wetumpka Herald Country/Territory United States Date 15/01/25 URL https://smb.thewetumpkaherald.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Norwood - Local Town Pages Country/Territory United States Date 15/01/25 URL https://pr.norwoodtownnews.com/article/FDA-approves-Lillys-Omvohr-mirikizumab-mrkz-for-Crohns-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease?storyId=678823d6462b49b7d5c1b34d Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Eli Lilly Country/Territory United States Date 15/01/25 URL https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-omvohr-mirikizumab-mrkz-crohns-disease Persons Marla Dubinsky Title FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease Media name/outlet Central Charts Country/Territory France Date 15/01/25 URL https://www.centralcharts.com/en/145854-lilly-and-co/news/4965053-fda-approves-lilly-s-omvoh-mirikizumab-mrkz-for-crohn-s-disease-expanding-its-use-to-the-second-major-type-of-inflammatory-bowel-disease Persons Marla Dubinsky